Invicta Animal Health has announced its appointment as exclusive veterinary distributor in the UK for Chloraprep, a licensed human product for cutaneous antisepsis prior to invasive procedures.
New veterinary pharmaceutical company Invicta Animal Health has announced its appointment as exclusive veterinary distributor in the UK for Chloraprep, a licensed human product for cutaneous antisepsis prior to invasive procedures.
According to Invicta, Chloraprep is a single use, easy to apply, sterile system, available in a variety of sizes and in clear and tinted versions to enhance the visibility of the area requiring antisepsis, for instance, prior to surgery.
The sterile solution is maintained in a glass ampoule inside a protective outer case and, to prevent contamination, the patented design ensures users don’t come into contact with either the contents or the patient’s skin.
Invicta managing director Rob Watkins said: “Most surgical site infections (SSIs) are the result of contamination from a patient’s own skin flora, a fact which highlights the importance of thorough and effective preparation of the skin as a proactive way to minimise the incidence of SSI’s in patients.”
Research has shown that Chloraprep, which contains 2% chlorhexidine and 70% isopropyl alcohol, has demonstrated significantly better antimicrobial activity than other combinations. Once applied, Chloraprep is active in 30 seconds and is effective for up to 48 hours.
Mr Watkins added: “The majority of UK hospitals and the Blood Transfusion Service already use Chloraprep and we are pleased to make this available under the provisions of the cascade.”
Chloraprep is available from Invicta Animal Health and full training and information on its use is also supplied.
- For further information, contact Invicta Animal Health on 01403 791313 or email email@example.com.